Creative Medical Technology Holdings (CELZ) Treasury Shares (2017 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Treasury Shares of $10000.0 for Q1 2026, little changed year-over-year from $10000.0 in Q1 2025, and little changed quarter-over-quarter from $10000.0 in Q4 2025.
Creative Medical Technology Holdings (CELZ) Treasury Shares (2017 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Treasury Shares for 4 consecutive years, with $10000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $10000.0 (changed 0.0% YoY), while the FY2025 annual figure was $10000.0, changed N/A from the prior year.
- Treasury Shares was little changed at $10000.0 in Q1 2026 per CELZ's latest filing, from $10000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $101250.0 in Q3 2024 and bottomed at $5000.0 in Q1 2025.
- Historically, Treasury Shares has averaged $39325.0 across 4 years, with a median of $22500.0 in 2023.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 132.51% — and 2025, when it plunged 97.76%.
- Creative Medical Technology Holdings' Treasury Shares stood at $270952.0 in 2023, then soared by 64.57% to $445916.0 in 2024, then slumped by 97.76% to $10000.0 in 2025, then changed by 0.0% to $10000.0 in 2026.
- Business Quant data shows CELZ's Treasury Shares at $10000.0 in Q1 2026, $10000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 2.72 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |